ICAM1 and cervical cancer: The regulation of cellular response to the hypoxia pathway was found as the most significantly downregulated signaling pathway upon ICAM1 neutralizing antibody treatment, but further studies are needed to characterize the specific pathways activated in cervical cancer cells.